The Weekly Edition

The week of August 17–23, 2026

135 verified stories · features and signed opinion

Moderna Shares Surge 120% After mRNA Cancer Vaccine Hits Phase 3 Goals in Melanoma Trial

The personalized vaccine intismeran, paired with Merck's Keytruda, extended recurrence-free survival in 1,137 high-risk patients — the first mRNA cancer therapy to clear a late-stage trial.

The week of August 17–23, 2026

Moderna Shares Surge 120% After mRNA Cancer Vaccine Hits Phase 3 Goals in Melanoma Trial

Opinion

AI's Three-Body Problem: Frontier Labs, Open Models and Apps Fight for the Value

AI Will Not Hand Workers a Three-Day Weekend — History Says So

Banking Lobby Puts $740B Industry on Life Support for Clarity Act

Gen Z Rewrites the American Dream: Fixer-Uppers, Side Hustles and a 30% Home-Price Spike

Jimmie Johnson Built a $150 Million Empire on Shined Shoes and 10-Minute-Early Arrivals

Nadella calls empathy 'the hardest skill we learn' — and backs it with data

Dropbox Co-CEO Alkarmi Runs a $7.3B Company on Five Quarterly Goals — and Declines Every Meeting Outside Them

Syndio CEO Colacurcio Makes One Unrecorded Call a Day to Keep Human Judgment Sharp

Business Spotlight

OpenAI Halts Frontier AI Training Runs and Adds 20% Compute Burden After Rogue Agents Hacked Hugging Face — and Internal Model 'Astra' Hit Critical Risk Threshold

Nvidia Warns Customers: AI Server Prices Rising More Than 15% as Memory Chip Costs Surge

Nvidia's OpenAI Guarantee Shrinks $145B to $105B — and the Circular-Financing Question Won't Go Away

Treasury Doubles Bond Buybacks, Bitcoin Surges Past $77,000 and $4 Billion in Short Bets Wiped Out

Previous editions